List of Tables
Table 1. Global Gene Therapy Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gene Therapy Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gene Therapy Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gene Therapy Products Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Gene Therapy Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gene Therapy Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gene Therapy Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gene Therapy Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gene Therapy Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gene Therapy Products, Product Type & Application
Table 12. Global Key Manufacturers of Gene Therapy Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Therapy Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 18. Global Gene Therapy Products Sales Market Share by Region (2020-2025)
Table 19. Global Gene Therapy Products Sales by Region (2026-2031) & (K Units)
Table 20. Global Gene Therapy Products Sales Market Share by Region (2026-2031)
Table 21. Global Gene Therapy Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gene Therapy Products Revenue Market Share by Region (2020-2025)
Table 23. Global Gene Therapy Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gene Therapy Products Revenue Market Share by Region (2026-2031)
Table 25. North America Gene Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 27. North America Gene Therapy Products Sales by Country (2026-2031) & (K Units)
Table 28. North America Gene Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gene Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gene Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 32. Europe Gene Therapy Products Sales by Country (2026-2031) & (K Units)
Table 33. Europe Gene Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gene Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gene Therapy Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Gene Therapy Products Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Gene Therapy Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gene Therapy Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Gene Therapy Products Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Gene Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gene Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gene Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Gene Therapy Products Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Gene Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gene Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gene Therapy Products Sales (K Units) by Type (2020-2025)
Table 51. Global Gene Therapy Products Sales (K Units) by Type (2026-2031)
Table 52. Global Gene Therapy Products Sales Market Share by Type (2020-2025)
Table 53. Global Gene Therapy Products Sales Market Share by Type (2026-2031)
Table 54. Global Gene Therapy Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gene Therapy Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gene Therapy Products Revenue Market Share by Type (2020-2025)
Table 57. Global Gene Therapy Products Revenue Market Share by Type (2026-2031)
Table 58. Global Gene Therapy Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Gene Therapy Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Gene Therapy Products Sales (K Units) by Application (2020-2025)
Table 61. Global Gene Therapy Products Sales (K Units) by Application (2026-2031)
Table 62. Global Gene Therapy Products Sales Market Share by Application (2020-2025)
Table 63. Global Gene Therapy Products Sales Market Share by Application (2026-2031)
Table 64. Global Gene Therapy Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gene Therapy Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gene Therapy Products Revenue Market Share by Application (2020-2025)
Table 67. Global Gene Therapy Products Revenue Market Share by Application (2026-2031)
Table 68. Global Gene Therapy Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Gene Therapy Products Price (US$/Unit) by Application (2026-2031)
Table 70. Bluebird Bio Company Information
Table 71. Bluebird Bio Description and Business Overview
Table 72. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bluebird Bio Gene Therapy Products Product
Table 74. Bluebird Bio Recent Developments/Updates
Table 75. Sangamo Company Information
Table 76. Sangamo Description and Business Overview
Table 77. Sangamo Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sangamo Gene Therapy Products Product
Table 79. Sangamo Recent Developments/Updates
Table 80. Spark Therapeutics Company Information
Table 81. Spark Therapeutics Description and Business Overview
Table 82. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Spark Therapeutics Gene Therapy Products Product
Table 84. Spark Therapeutics Recent Developments/Updates
Table 85. Dimension Therapeutics Company Information
Table 86. Dimension Therapeutics Description and Business Overview
Table 87. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Dimension Therapeutics Gene Therapy Products Product
Table 89. Dimension Therapeutics Recent Developments/Updates
Table 90. Avalanche Bio Company Information
Table 91. Avalanche Bio Description and Business Overview
Table 92. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Avalanche Bio Gene Therapy Products Product
Table 94. Avalanche Bio Recent Developments/Updates
Table 95. Celladon Company Information
Table 96. Celladon Description and Business Overview
Table 97. Celladon Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Celladon Gene Therapy Products Product
Table 99. Celladon Recent Developments/Updates
Table 100. Vical Inc. Company Information
Table 101. Vical Inc. Description and Business Overview
Table 102. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Vical Inc. Gene Therapy Products Product
Table 104. Vical Inc. Recent Developments/Updates
Table 105. Advantagene Company Information
Table 106. Advantagene Description and Business Overview
Table 107. Advantagene Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Advantagene Gene Therapy Products Product
Table 109. Advantagene Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Gene Therapy Products Distributors List
Table 113. Gene Therapy Products Customers List
Table 114. Gene Therapy Products Market Trends
Table 115. Gene Therapy Products Market Drivers
Table 116. Gene Therapy Products Market Challenges
Table 117. Gene Therapy Products Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gene Therapy Products
Figure 2. Global Gene Therapy Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy Products Market Share by Type: 2024 & 2031
Figure 4. Ex vivo Product Picture
Figure 5. In Vivo Product Picture
Figure 6. Global Gene Therapy Products Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy Products Market Share by Application: 2024 & 2031
Figure 8. Cancer
Figure 9. Monogenic
Figure 10. Infectious disease
Figure 11. Cardiovascular disease
Figure 12. Other
Figure 13. Global Gene Therapy Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Therapy Products Market Size (2020-2031) & (US$ Million)
Figure 15. Global Gene Therapy Products Sales (2020-2031) & (K Units)
Figure 16. Global Gene Therapy Products Average Price (US$/Unit) & (2020-2031)
Figure 17. Gene Therapy Products Report Years Considered
Figure 18. Gene Therapy Products Sales Share by Manufacturers in 2024
Figure 19. Global Gene Therapy Products Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Gene Therapy Products Players: Market Share by Revenue in Gene Therapy Products in 2024
Figure 21. Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Gene Therapy Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Gene Therapy Products Sales Market Share by Country (2020-2031)
Figure 24. North America Gene Therapy Products Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Gene Therapy Products Sales Market Share by Country (2020-2031)
Figure 28. Europe Gene Therapy Products Revenue Market Share by Country (2020-2031)
Figure 29. Germany Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Gene Therapy Products Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Gene Therapy Products Revenue Market Share by Region (2020-2031)
Figure 36. China Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Gene Therapy Products Sales Market Share by Country (2020-2031)
Figure 47. Latin America Gene Therapy Products Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Gene Therapy Products Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Gene Therapy Products Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Gene Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Gene Therapy Products by Type (2020-2031)
Figure 57. Global Revenue Market Share of Gene Therapy Products by Type (2020-2031)
Figure 58. Global Gene Therapy Products Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Gene Therapy Products by Application (2020-2031)
Figure 60. Global Revenue Market Share of Gene Therapy Products by Application (2020-2031)
Figure 61. Global Gene Therapy Products Price (US$/Unit) by Application (2020-2031)
Figure 62. Gene Therapy Products Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
